However, TESC was found to be highly expressed in cholangiocarcinoma and mediate tumor progression by promoting the TGF-α/EGFR-FOXM1 axis, which is different from our predicted expression model (32). The gene discussed is EGFR; the disease is cholangiocarcinoma.